Cabaletta Bio
CABA
71 hedge funds and large institutions have $204M invested in Cabaletta Bio in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 13 closing their positions.
567% more call options, than puts
Call options by funds: $800K | Put options by funds: $120K
85% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 13
46% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 13
18% more funds holding
Funds holding: 60 → 71 (+11)
12% more capital invested
Capital invested by funds: $183M → $204M (+$21.2M)
10.84% more ownership
Funds ownership: 67.79% → 78.62% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$30.7M |
| 2 |
CC
Commodore Capital
New York
|
+$7.72M |
| 3 |
Jennison Associates
New York
|
+$7.31M |
| 4 |
PA
Perceptive Advisors
New York
|
+$3.81M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$6.88M |
| 2 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$3.48M |
| 3 |
EP
Eversept Partners
New York
|
-$2.62M |
| 4 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$2.47M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.78M |
CABA Hedge Fund Activity: Q1 2023 in Review
71 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q1 2023, worth a combined $204M — up 12% from $183M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CABA positions and 13 closed out — a net gain of 11 holders — while 19 added to existing stakes and 13 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $30.7M. The largest seller was Blackstone Inc, cutting an estimated $6.88M.
- 71 institutional investors held Cabaletta Bio (CABA) as of Q1 2023, up from 60 in Q4 2022.
- Funds reported $204M of Cabaletta Bio stock for Q1 2023, up 12% quarter-over-quarter.
- 24 funds opened new Cabaletta Bio positions in Q1 2023 and 13 closed out, a net change of +11 holders.
- The largest Cabaletta Bio buyer in Q1 2023 was Fred Alger Management, an estimated $30.7M added.
- The largest Cabaletta Bio seller in Q1 2023 was Blackstone Inc, an estimated $6.88M sold.
Based on aggregated 13F filings for Q1 2023.